Meghan Kelly

Business Services

• Represented an insurance agency in its $510 million sale to a global insurance brokerage, risk management, and consulting services firm
• Represented of a nonprofit health insurance company in its combination with a nonprofit health services company, creating New England’s largest nonprofit health services organization
• Represented a distributor of water infrastructure solutions in its sale to a private equity backed water treatment company
• Represented a branded hospitality platform in its acquisition of the outdoor IP portfolio of a sports retail company
• Represented a regional bank holding company and its subsidiary in its merger with a bank holding company in an all-stock transaction valued at $209 million
• Represented an IT service management company in its acquisition by a leading provider of information technology and business processing services through its wholly owned US subsidiary
• Represented of a transportation logistics company for the life sciences and government sectors in its acquisition by a supply chain management company
• Represented a private equity firm in its recapitalization and merger of two aerial inspection companies
• Represented a digital payments management provider of business services for SMEs, fintechs, and social impact entities across Africa in its acquisition by an African digital payment hub

Technology

• Represented a leading provider of eSource and other eClinical technologies in a significant investment from a global growth-oriented private equity firm
• Represented a bitcoin mining company in its sale to an AI infrastructure company
• Represented a digital advertising company in its acquisition of a news aggregator
• Represented a market research company in its disposition of a course evaluation software company and in its eventual sale to a market research firm
• Represented a developer of software for penetration testers and red teams in its acquisition by a cybersecurity company
• Represented an Internet of Things (IoT) solutions provider for the food services industry in its acquisition by merger by a food service manufacturing company
• Represented a software development company in its majority recapitalization by a private equity firm

Consumer Products and Manufacturing

• Represented a snack company in its sale to a beverage manufacturing company
• Represented a biltong snack company in its acquisition by a leading air-dried meat snack company
• Represented a cupcake bakery in its acquisition by a food gift retailer
• Represented a company that develops, produces, and markets yeast, bacteria, and specialty ingredients in its acquisition of yeast manufacturing operations in Minnesota, in its asset acquisition of a yeast manufacturing plant and business based in North Dakota and in its acquisition of a full-service contract manufacturer specializing in the formation and supply of probiotic solutions
• Represented a leading lighting manufacturer in its acquisition of a Boston-based company that specializes in industrial IoT solutions
• Represented a leading medical specialty manufacturer of infection prevention, wound care, clinical chemistry, patient monitoring, and medical and surgical consumable products in its acquisition by a leading North American healthcare specialty manufacturer focused on oral and dental care and medical end markets
• Represented a provider of valves and other highly engineered products for markets including oil and gas, power generation, and aerospace and defense in its acquisition of a developer and manufacturer of high-quality severe service valves for oil and gas refineries for $210 million
• Represented a manufacturer of engineered multilayer fabrics for automotive and other uses in its joint venture with the automotive headliner and specialty industrial fabrics business of a fabric manufacturer
• Represented a manufacturer of automotive, solar, safety, and security films in its acquisition of select assets of an established supplier of protection films

Life Sciences

• Represented a clinical-stage biotech company in its sale to a pharmaceutical company
• Represented a full-service CRO focused on providing early phase oncology clinical development services to the biotechnology industry in its acquisition by a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry

Emerging Companies

• Represented a food packaging company in a Series A financing led by a venture capital company with participation from three other venture capital companies
• Represented a software company in a $21 million investment from a private equity firm
• Represented a developer and manufacturer of low-carb, gluten-free cauliflower products in a Series A financing round
• Represented a probiotic water kefir maker in a financing round
• Represented a food company in a round of financing led by a private equity firm
• Represented a cold brew coffee maker in its Series A equity round of financing